Key result
Elevated NT-proBNP in heart failure is linked to false-positive Coombs tests at median levels near ~10,800 pg/mL.
Why the study?
A retrospective study described that NT-proBNP could be an additional cause of false positives in the Coombs test.
Is elevated NT-proBNP associated with a false-positive Coombs test in patients with heart failure?
Observational (n=36)
No
Is elevated NT-proBNP associated with a false-positive Coombs test in patients with heart failure?
Elevated NT-proBNP in heart failure patients may cause false-positive Coombs tests, highlighting a potential diagnostic pitfall when evaluating for hemolytic anemia.
Answers are grounded in this paper and cite their sources.
May represent NT-proBNP interference with Coombs testing in HF; leaves open diagnostic pitfall needing prospective validation before practice change.
Background and Objectives The human antiglobulin test or Coombs' test is a key tool in the diagnosis and classification of haemolytic anaemia and could present as falsely positive. A retrospective study has described that B‐type natriuretic peptide (NT‐proBNP), a biomarker used for heart failure (HF), could be an additional cause of false positives in the Coombs test. Materials and Methods A prospective, observational, single‐centre study was conducted in adult patients diagnosed with HF between October 2024 and March 2025 at a tertiary hospital. The Coombs' test was considered as false positive in cases in which the specificity of the test included immunoglobulin G (IgG), the subsequent elution yielded a negative result, and blood haemolysis parameters were within normal ranges. Results Thirty‐six patients were included, of whom nine (25%) had a false‐positive Coombs test. These patients had significantly higher levels of NT‐proBNP (10,825 pg/mL [2587–35,000] vs. 3314 pg/mL [278–11,856], p = 0.0076) and lower glomerular filtration rate (35.3 mL/min/1.73 m 2 [23.6–46.3] vs. 63.3 mL/min/1.73 m 2 [21.9–90.0], p = 0.0055) compared to patients with a negative Coombs test. No statistically significant associations were found with drugs used concomitantly for HF. Conclusion The results suggest that elevated NT‐proBNP could also be a cause of false positives in the Coombs test.
No takes yet. Share an insight, caveat, or question.
Álvarez et al. (2026) conducted an observational in Heart failure (n=36). False-positive Coombs test vs. Negative Coombs test was evaluated on NT-proBNP levels (pg/mL) (p=0.0076). Elevated NT-proBNP in heart failure patients was associated with a false-positive Coombs test, with median levels of 10,825 pg/mL vs. 3314 pg/mL in negative tests.
Synapse has enriched 10 related papers. Consider them for comparative context: